Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2022-03-31 00:00:00 ET · period of report 2022-03-29 · accession 0001209191-22-021832 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 2022-03-29 | RLAY | Porter Andy | Chief Administrative Off | S - Sale | $29.87 | -294 | 47.0K | -0.6% | -$8,782 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-29 | S | D | 294 | $29.87 | 47,023 | D | — | — | (F1) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 875 shares of restricted stock units ("RSUs") on March 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Includes 34,670 shares underlying RSUs. |